OGG1 and Alzheimer disease: The concentration of OGG1 in serum and lymphocytes isolated from AD patients may be decreased in the course of the disease [37, 40], and the mRNA expression of certain isoforms of OGG1 are significantly dysregulated in AD, and therefore may impede the OGG1 function and serve as AD biomarker [41].